https://orcid.org/0000-0002-6360-0113
References
- Valentino LA. Blood-induced joint disease: the pathophysiology of hemophilic arthropathy. J Thromb Haemost. 2010;8(9):1895–1902. doi:10.1111/j.1538-7836.2010.03962.x
- Rodriguez-Merchan EC. Hemophilic arthropathy: a teaching approach devoted to hemophilia treaters in under-development countries. Expert Rev Hematol. 2021;14(10):887–896. doi:10.1080/17474086.2021.1977118
- Négrier C, Mahlangu J, Lehle M, et al. Emicizumab in people with moderate or mild haemophilia a (HAVEN 6): a multicentre, open-label, single-arm, phase 3 study. Lancet Haematol. 2023;10(3):S2352-3026(22)00377–5. doi:10.1016/S2352-3026(22)00377-5
- von Drygalski A, Chowdary P, Kulkarni R, et al. XTEND-1 trial group. Efanesoctocog alfa prophylaxis for patients with severe hemophilia A. N Engl J Med. 2023;388(4):310–318.
- Tagliaferri A, Molinari AC, Peyvandi F, et al. IDEAL study: a real-world assessment of pattern of use and clinical outcomes with recombinant coagulation factor IX albumin fusion protein (rIX-FP) in patients with haemophilia B in Italy. Haemophilia. 2023;29(1):135–144. doi:10.1111/hae.14689
- Kragh N, Tytula A, Pochopien M, et al. Cost-effectiveness of recombinant factor VIII Fc versus emicizumab for prophylaxis in adults and adolescents with haemophilia a without inhibitors in the UK. Eur J Haematol. 2023;110(3):262–270. doi:10.1111/ejh.13901
- van Leeuwen FHP, van Bergen EPD, Timmer MA, et al. MRI evidence for subclinical joint bleeding in a Dutch population of people with severe hemophilia on prophylaxis. J Thromb Haemost. 2023 Feb 7;S1538-7836(23)00098–3.
- Querol F, Rodriguez-Merchan EC. The role of ultrasonography in the diagnosis of the musculo-skeletal problems of haemophilia. Haemophilia. 2012;18(3):e215–e226. doi:10.1111/j.1365-2516.2011.02680.x
- Sierra Aisa C, Lucía Cuesta JF, Rubio Martínez A, et al. Comparison of ultrasound and magnetic resonance imaging for diagnosis and follow-up of joint lesions in patients with haemophilia. Haemophilia. 2014;20(1):e51–e57. doi:10.1111/hae.12268
- Merchan ECR, De Orbe A, Gago J. Ultrasound in the diagnosis of the early stages of hemophilic arthropathy of the knee. Acta Orthop Belg. 1992;58(2):122–125.
- De la Corte-Rodriguez H, Rodriguez-Merchan EC, Alvarez-Roman MT, et al. Clinical assessment and point of care ultrasonography: how to diagnose haemophilic synovitis. Haemophilia. 2022;28(1):138–144. doi:10.1111/hae.14441
- Adramerina A, Teli A, Symeonidis S, et al. Treatment individualization using pharmacokinetic studies and joint ultrasound imaging in pediatric patients with hemophilia. J Pediatr Hematol Oncol. 2022;44(5):237–242. doi:10.1097/MPH.0000000000002323
- Gallastegui N, Steiner B, Aguero P, et al. The role of point-of-care musculoskeletal ultrasound for routine joint evaluation and management in the hemophilia clinic - a real world experience. BMC Musculoskelet Disord. 2022;23(1):1111. doi:10.1186/s12891-022-06042-w
- Minno MNDD, Martinoli C, Pasta G, et al. How to assess, detect, and manage joint involvement in the era of transformational therapies: role of point-of-care ultrasound. Haemophilia. 2023;29(1):1–10. doi:10.1111/hae.14657
- Acharya SS, Schloss R, Dyke JP, et al. Power doppler sonography in the diagnosis of hemophilic synovitis – a promising tool. J Thromb Haemost. 2008;6(12):2055–2061. doi:10.1111/j.1538-7836.2008.03160.x
- Ma F, Zhang YR, Luke KH, et al. Value of contrast-enhanced ultrasound in evaluating synovitis and predicting recurrent joint bleeding of hemophilia. Curr Med Sci. 2022;42(2):439–446. doi:10.1007/s11596-022-2520-9
- Gopal S, Barnes RFW, Volland LM, et al. Patient-derived assessment tool using musculoskeletal ultrasound for validation of haemarthrosis. Haemophilia. 2022;28(5):842–848. doi:10.1111/hae.14591